Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Clinical Nephrology|May 1, 1979
Membranoproliferative glomerulonephritis type 1: comparison of natural history in children and adultsA B Magil, J D Price, G Bower, et al.
Anaesthesia|October 18, 2006
A randomised controlled trial of the effect of continuous electronic physiological monitoring on the adverse event rate in high risk medical and surgical patientsP J Watkinson, V S Barber, J D Price, et al.
The Journal of Hospital Infection|April 20, 2006
Deep wound infection after proximal femoral fracture: consequences and costsT C B Pollard, J E Newman, N J Barlow, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjectsK M McErlane, J Axelson, R Vaughan, et al.
The American Journal of Medicine|October 1, 1979
Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophyJ C Prior, E C Cameron, H S Ballon, et al.
Neurology|February 1, 1985
Brain gamma-aminobutyric acid deficiency in dialysis encephalopathyV P Sweeney, T L Perry, J D Price, et al.
Clinical and Experimental Immunology|May 29, 2013
Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled studyJ D Price, G Linder, W P Li, et al.
Canadian Anaesthetists' Society Journal|September 1, 1983
Placental transport of metoclopramide: assessment of maternal and neonatal effectsM Bylsma-Howell, K W Riggs, G H McMorland, et al.
British Journal of Clinical Pharmacology|October 1, 1988
Linearity of metoclopramide kinetics at doses of 5-20 mgM R Wright, J E Axelson, D W Rurak, et al.
British Journal of Clinical Pharmacology|October 1, 1988
Effect of haemodialysis on metoclopramide kinetics in patients with severe renal failureM R Wright, J E Axelson, D W Rurak, et al.
Pageof 10